共 6 条
- [6] Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial [J]. LANCET HAEMATOLOGY, 2023, 10 (12): : E976 - E984